- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Dapagliflozin; 2. dapagliflozin with metformin; 3. dapagliflozin with saxagliptin – November 2017
Dapagliflozin, 2. Dapagliflozin with metformin, 3. Dapagliflozin with saxagliptin: 1. Tablet 10 mg (
Last updated
2 March 2018